Amycretin vs Exenatide

Molecule comparison

Last updated 2026-05-28 15:46 UTC

Amycretin is an experimental drug that combines signals from two gut hormones, amylin and GLP-1, and is not yet approved for any use. Exenatide, sold as Byetta or Bydureon, is an FDA-approved GLP-1-only drug used to treat type 2 diabetes; it comes as a daily injection (Byetta) or a weekly injection (Bydureon).

AI summary of the sources below.

	Amycretin	Exenatide
Mechanism	Amylin and GLP-1 receptor co-agonist	GLP-1 receptor agonist
Status	Pipeline	Approved
Branded products	—	byetta, bydureon

Compare full details on the Amycretin and Exenatide pages.